baber/WOPTO huggingface dataset:
Patent PT-2064532-E (PT)
Title: System for detecting the pressure in a vehicle tyre and/or speed of the vehicle
Inventor: PINGEL ULRICH
IPC: G01L17/00
Filed: 2007-09-13
Abstract: A system for detecting the pressure in a pneumatic vehicle tire which is mounted on a vehicle and/or the speed of the vehicle, having an arrangement composed of load sensors which supplies force signals for a two-dimensional pattern of the distribution of force which is exerted by the vehicle tire in contact with the sensors when the vehicle moves over the arrangement, a computer which is programmed in such a way that it defines the tire pressure and/or the speed on the basis of the distribution of force independently of the method of manufacture or the model of the tire and of the vehicle, and a device for displaying the pressure and/or the speed, is characterized in that the arrangement composed of load sensors comprises at least two series of load sensors which are arranged one behind the other in the direction of travel, wherein at least one row of load sensors is offset with respect to one or more rows of the load sensors by a predetermined absolute value transversely with respect to the direction of travel.
Patent PT-2009025-E (PT)
Title: Method of inhibiting osteoclast activity
Inventor: ANDERSON DIRK M
IPC: A61P19/08
Filed: 1999-05-13
Abstract: Isolated soluble RANK receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate osteoclastogenesis, and hence treat disease in which there is excess bone loss.
Patent PT-2319500-E (PT)
Title: Rapid acting drug delivery compositions
Inventor: STEINER SOLOMON S
IPC: A61K38/29
Filed: 2005-03-11
Abstract: Drug formulations for systemic drug delivery with improved stability and rapid onset of action are described herein. The formulations are administered sublingually or via subcutaneous injection. The formulations contain an active agent and one or more excipients, selected to increase the rate of dissolution. In the preferred embodiment, the drug is insulin, and the excipients include a zinc metal chelator such as EDTA and a solubilizing acid such as acetic acid, ascorbic acid, or citric acid.
Patent PT-578347-E (PT)
Inventor: ABOLT ROBERT B
IPC: B01D15/04
Filed: 1993-03-01
Abstract: The present invention relates to the removal of metal ion contaminants as their anionic complexes from a variety of solutions containing said metal ion contaminants on an anion exchange resin, and the separation and purification of the anionic metal complexes by chromatographic elution utilizing a specially designed apparatus that enhances and maximizes the effects caused by different metal complex dissociation constants.
Patent PT-660891-E (PT)
Inventor: RYAN RICHARD J
IPC: B29C55/22
Filed: 1993-09-20
Abstract: A method and apparatus for heat stretching a synthetic fiber rope. The rope is buoyed in a vessel containing a liquid medium, and this is heated to a predetermined stretching temperature. Tension is applied to the heated portion of the rope so as to stretch this to a predetermined increase in length. The process may be batchwise, or it may be continuous. In the batch process, a length of the rope is stretched in the heating vessel by a draw rod. In the continuous process, feed and take-up capstans pass the rope through a heating chamber, and then through a cooling chamber. The capstans are operated at different speeds so that the rope is tensioned and stretched between them within the vessel.
Patent PT-622182-E (PT)
Inventor: REINERS ULRICH
IPC: B32B27/08
Filed: 1994-04-18
Abstract: The present invention relates to multilayered, heat-sealable, recycled film comprising at least one scrap layer and a heat-sealable layer, where     - the film is thermoformable, - the scrap layer comprises polyamide (nylon)/polyolefin recyclate and an adhesion promoter, where the recyclate content in the scrap layer is from 60 to 98% by weight, - the recyclate has a polyamide content of from 3 to 45% by weight, and - the heat-sealable layer has a single- or multilayer structure and comprises polyolefinic polymer or copolymer, where the layers can be identical or different.
Patent PT-615751-E (PT)
Inventor: HAGAN RUSSELL MICHAEL
IPC: A61K31/47
Filed: 1994-03-17
Abstract: The present invention relates to the use of certain tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis.
Patent PT-650374-E (PT)
Inventor: PATAT JEAN-LOUIS
IPC: A61L27/22
Filed: 1994-05-11
Abstract: PCT No. PCT/FR94/00565 Sec. 371 Date Feb. 2, 1995 Sec. 102(e) Date Feb. 2, 1995 PCT Filed May 11, 1994 PCT Pub. No. WO94/26322 PCT Pub. Date Nov. 24, 1994A method for treating a living organism includes fitting in the living organism a bioabsorbable implant. The bioabsorbable implant includes a support of porous calcium carbonate based material for supporting at least one growth factor. The calcium carbonate based support material forms an external wall of the support.
Patent PT-768627-E (PT)
Inventor: GIBB DAVID
IPC: G07F9/02
Filed: 1996-09-25
Abstract: An open shelf bar arrangement for an hotel or like establishment comprises a plurality of open shelf bars (3), each having shelf units (23) for receiving articles (45) and control arrangements for determining the presence or absence of articles and transmitting data thereabout. A central processor (5) is provided for receiving data from the bar control arrangement of each bar (3) and for controlling the bars, the central processor (5) providing data to reporting means (11) for providing reports on the operation of the bars (3) and to a central billing arrangement (9) for adding the cost of items taken from the bars to appropriate customers billing. The invention also includes the bar control arrangement and the bar shelf units (23). <IMAGE>
Patent PT-1011384-E (PT)
Inventor: OLSEN TERJE STEINAR
IPC: A47C1/034
Filed: 1996-06-14
Abstract: PCT No. PCT/NO96/00146 Sec. 371 Date Apr. 6, 1998 Sec. 102(e) Date Apr. 6, 1998 PCT Filed Jun. 14, 1996 PCT Pub. No. WO97/00035 PCT Pub. Date Jan. 3, 1997Adjustable chair equipped with a calf supporting board which by means of an over-center mechanism and a gas spring can be brought to a horizontal position when the angle between the seat and the back of the seat increases, the board being foldable when the angle is decreased.
Patent PT-853639-E (PT)
Inventor: RIMMER IAN
IPC: C08G18/80
Filed: 1996-10-04
Abstract: PCT No. PCT/GB96/02440 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Oct. 4, 1996 PCT Pub. No. WO97/12924 PCT Pub. Date Apr. 10, 1997A water dispersible blocked polyisocyanate of formula (I) R-Ym, where R is an m valent group comprising an aliphatic, cycloaliphatic, heterocyclic or aromatic group and comprising at least three consecutive ethylene oxide groups or at least one residue of a polyhydroxy carboxylic acid, and each group Y, which may be the same or different, is a group of formula (II), where each R1 is the same or different when n is more than 1 and each R1 is an alkyl, alkenyl, aralkyl, N-substituted carbamyl, phenyl, NO2, halogen or a group -C(O)-O-R2 where R2 is hydrogen or an alkyl group; n is 0, 1, 2 or 3; and m is an integer of 2 or more.
Patent PT-863981-E (PT)
Title: Detection, prevention and treatment of papillomatous digital dermatitis
Inventor: WALLIS DALE
IPC: A61K39/00
Filed: 1997-07-31
Abstract: The present invention relates to the use of Serpens spp. bacteria or bacterin in compositions, such vaccines, and methods for the detection, prevention and/or treatment of Papillomatous Digital Dermatitis in ruminants. The present invention also provides biologically pure Serpens spp. strain HBL-112, and biologically pure Serpens spp. strain HBL-112 bacterin.
Patent PT-897569-E (PT)
Inventor: FISHER JOHN
IPC: G07D7/04
Filed: 1997-12-12
Abstract: A method for detecting the presence of magnetic elongated particles in a substrate the base material of which has magnetic properties substantially differing from the corresponding magnetic properties of the elongated particles. The elongated particles have such a long and thin form that their demagnetisation factor N is smaller than +E,fra 1/250+EE , they have a diameter smaller than 30 micrometer and a magnetic saturation field greater than 100 A/m. The method comprising the following steps: (a) emitting an electromagnetic source signal of one or more particular base frequencies to the substrate so that any present magnetic elongated particles go into a non-linear part of their B-H curve for at least part of a cycle of the source signal; (b) detecting an electromagnetic detection signal emanating from the substrate; (c) testing the detection signal for the presence of particular higher harmonics of the base frequencies or of any linear combination of the base frequencies or of the harmonics, the particular higher harmonics being indicative of the presence of the magnetic elongated particles.
Patent PT-1102687-E (PT)
Title: Vehicle suspension with linked air bags
Inventor: HAIRE WILLIAM ARTHUR
IPC: B60G11/26
Filed: 1999-07-29
Abstract: A suspension system for use with a vehicle having at least one wheel (12); the suspension system including: at least two airbags (24, 25) arranged as a forward air bag (24) and a rear air bag (25), the forward air bag (24) and the rear air bag (25) being operatively connected to enable high flow-rates of air between them. A vehicle suspension wherein a front differential and a rear differential have extending therebetween a height valve rocker and a link extending from the midpoint of the length of the height valve rocker to a height valve is also disclosed.
Patent IE-42400-L (IE)
Title: Preparing pigmented polyesters
IPC: C08G63/00
Filed: 1976-01-16
Abstract: There is disclosed an improvement in the pigmenting of polyesters derived from free dicarboxylic acids and glycols employing a slurry consisting of pigmenting agent and a glycol which improvement comprises heating said slurry to a temperature ranging from about 90 DEG C. to about 1 DEG to 2 DEG C. below the boiling point of the glycol constituent and adding the heated slurry to the polyester forming reactants when the temperature of said reactants ranges from about 210 DEG to 240 DEG C. and the pressure in the reaction vessel employed ranges from about 20 to 70 pounds per square inch gauge.
[US3932345A]
Patent IE-42975-L (IE)
Title: Conductive carbon black for dry batteries
IPC: C09C1/48
Filed: 1976-04-09
Abstract: Conductive carbon black for use in depolarization masses in dry batteries is produced. To this end, an aqueous suspension of carbon black having an AS-number higher than 15 and having been obtained by subjecting hydrocarbons, which are liquid at room temperature, to thermal conversion at 1200 DEG -2000 DEG C, under 1-80 atmospheres, and in the presence of oxygen or oxygen-containing gas and, if desired, steam, and water-scrubbing the resulting carbon black-containing reaction gas, is intimately mixed at 5 DEG -120 DEG C, under 1-20 atmospheres, in liquid phase and for 1-20 minutes with 0.5-10 g, per gram of carbon black, of vaporizable aliphatic or cycloaliphatic hydrocarbons, the resulting carbon black is separated from the liquid phase, heated and thereby freed from hydrocarbons and water, and the temperature is finally increased for 2-30 minutes to 1100 DEG -2200 DEG C.
[US4061719A]
Patent FI-803251-L (FI)
Inventor: ROSENTHAL HEINRICH
IPC: C08K5/17
Filed: 1980-10-15
Abstract: A sealable multilayer film for packaging comprising a polypropylene film and at least one sealing layer of an ethylene homo- or copolymer wherein the sealing layer contains an additive combination of a long-chain amine, a thermoplastic polymer incompatible with the sealing polymer and a polydialkyl siloxane.
Patent FI-812632-L (FI)
Inventor: JONES LESLIE EDWARD
IPC: C22C33/02
Filed: 1981-08-26
Abstract: In the hot briquetting of cast iron particles the cast iron particles are supplied to a furnace in which they are heated to the plastics range. Prior to reaching the furnace, carbon is added to the particles. The hot particles leaving the furnace are pressed into briquettes. The addition of carbon to the particles substantially increases the carbon content of the briquettes on furnace re-melt.
Patent FI-851476-L (FI)
Inventor: LINDLEY MICHAEL GEORGE
IPC: A23L21/10
Filed: 1985-04-12
Abstract: The sweetness of an ingestible product or oral composition containing a sweetening sugar or sugar alcohol in relatively large quantities can be reduced and/or the flavour enhanced by incorporation of at least one compound of the general formula (I)in which m represents 0 or 1, A represents a homocyclic or heterocyclic aromatic group with one or more rings; and B represents a hydrogen atom, a lower aliphatic group with 1-3 carbon atoms or a phenyl group; or, when m represents 0, A and B together represent a bivalent homocyclic or heterocyclic aromatic group with two or more rings, or a methylidene group carrying as a substituent a homocyclic or heterocyclic aromatic group with one or more rings; an aromatic ring of A, or of A and B together, optionally carrying one to three substituents selected from lower alkoxy groups, lower alkyl alkenyl groups, formyl or acetyl groups, hydroxy groups or acyloxy groups, and halogen atoms;C represents a hydrogen atom or an alkyl group or, when m represents 0, a hydroxy or alkoxy group;D represents an oxygen or sulphur atom;X<sup>+</sup> represents a hydrogen ion or another physiologically compatible cation;with the proviso that m represents 1 when S represents a substituted or unsubstituted phenyl group and Band C both represent hydrogen atoms; or when A represents an unsubstituted phenyl group, B represents an alkyl group and C represents a hydrogen atom.
Patent FI-851707-L (FI)
Inventor: WILMS KARL-HEINZ
IPC: A61B3/10
Filed: 1985-04-29
Abstract: A device is described for the connection of operating light, as well as of an observation and/or spotlight, with eye examination equipment, for example slit lamp equipment, the lamp 1 and observation device of which are rotatable around a vertical axis of rotation 3 which passes through an eye 14 which is to be examined. In the device according to the invention, the operating light beam and the observation and/or spotlight beam are absolutely coaxial. The coaxial light beams are first of all introduced into the axis 3 of the slit lamp equipment, which takes the form of a hollow axis, and then deflected through a first optical device 7, approximately at right angles to the axis of rotation, into the observation device holder 2' and deflected through a second optical device 8 in this holder so as to be approximately parallel with the rotational axis 3, and finally joined via a third optical device  10 to the observation device's beam path 12 outside the rotational axis of the eye examination equipment. <IMAGE>
Patent FI-851934-L (FI)
Inventor: BRADBURY ROBERT HUGH
IPC: C07D498/04
Filed: 1985-05-15
Abstract: (<sub>57</sub>) A cephalosporin derivative of the formula I:in which X is S, O, CH<sub>2</sub> or SO,represents one of C-7 acyl groups known in the cephalos porin art, R3 is hydrogen or methoxy, R4 is hydrogen, optionally substituted alkyl or allyl, and R5 is an aromatic heterocyclic ring system which is linked via carbon, and which contains a quaternised nitrogen atom.
Patent IE-37998-L (IE)
Title: Indole derivatives
IPC: A61K31/505
Filed: 1972-09-28
Abstract: 1356834 Therapeutic compositions IMPERRIAL CHEMICAL INDUSTRIES Ltd 27 Sept 1972 [3 Nov 1971 19 April 1972 30 June 1972] 51086/71 18116/72 and 30767/72 Heading A5B [Also in Division C2] Therapeutic compositions having antiinflamatory, analgesic and antipyretic activity, and which may be administered orally, parenterally, rectally or topically, comprise compounds of formula and their pharmaceutically acceptable salts, wherein R<SP>1</SP> is a C-linked heterocyclic radical (the C being conjugated with heterocyclic N) optionally containing 1 or 2 substituents selected from C 1-5 alkyl, alkoxy or alkylthio, NH 2 , halogen, CF 3 , CC-l 3 or Ph, and being pyrimidyl, quinolyl, isoquinolyl, cinnolinyl, quinazolinyl, quinoxalinyl, benzothiazolyl or benzoxazolyl; R<SP>2</SP> is H or C 1-3 alkyl; R<SP>3</SP>, R<SP>4</SP> are each H or Me; R<SP>5</SP> is COR<SP>7</SP> or CH 2 OR<SP>8</SP>; R<SP>6</SP> is H, -O(CH 2 ) 1-2 O-, or 1 or 2 of C 1-5 alkyl or alkoxy, halogen and di(C 1-5 alkyl)- amino; R<SP>7</SP> is OH, C 1-5 alkoxy[possibly di(C 1-5 alkyl)amino substituted], PhO, PhCH 2 O, (C 3-6 cycloalkyl)methoxy, NH 2 (possibly mono- or di-C 1-5 alkyl-substituted), PhNH, NHNH 2 or 1,3-dicyclohexylureido; and R<SP>8</SP> is H or C 1-6 alkonyl. The compositions may also contain a known antiinflammatory and/or analgeric compound, e.g. aspirin, parectamol, codeine, chloroquine, phenylbutazone, oxyphenbutazone, indomethacin, mefenamic acid, fluofenamic acid, ibufenac or an anti-inflammatory steroid such as prednisolone, and in the case of those intended for oral administration, an antacid, e.g. aluminium hydroxide and/or a uricosuric agent, e.g. probenecid.
[GB1356834A]
Patent IE-37701-L (IE)
Title: Aminoalkanol derivatives
IPC: C07C255/54
Filed: 1972-11-14
Abstract: 1-(3,4-Dimethoxyphenethylamino)-3-(substituted phenoxy)-2-propanols; and acid-addition salts. The substituent in the 3-(substituted phenoxy) group can be lower alkoxy, chloro, cyano, hydroxymethyl, acetyl, m-lower alkyl, or o-allyl. The compounds are pharmacological agents, especially beta-adrenergic blocking agents with cardio-selective activity. They can be produced by reacting a 1-halo-3-(substituted phenoxy)-2-propanol with 3,4-dimethoxyphenethylamine; or by reacting a 1,2-epoxy-3-(substituted phenoxy)propane with 3,4-dimethoxyphenethylamine. Starting materials for use in those processes are obtained by reacting a phenol or a sodium phenolate with epichlorohydrin under varying conditions.
[US3857891A]
Patent IE-41191-L (IE)
Title: Manufacture of 6 - methyl - 3, 4 - dihydro - 1, 2, 3 -¹oxathiazin - 4 - one - 2, 2 - dioxide.
IPC: A23L27/30
Filed: 1975-07-17
Abstract: 6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and the nontoxic salts thereof are prepared by reacting acetoacetic acid with fluorosulfonyl isocyanate at a temperature of from -20 DEG C to +50 DEG C in the presence of from 0.5 to 2 moles, calculated on the FSI used, of an alkali methal fluoride or a tertiary amine of the formula N(R1)(R2)(R3) in which R1, R2, R3 represent identical or different alkyl radicals having from 1 to 10 carbon atoms, two of the radicals R1 to R3 optionally form together an alkylene radical having from 4 to 5 carbon atoms which may contain N, O, or S as hetero atom, or one of the radicals R1 to R3 represents a phenyl radical, or of pyridine or quinoline, or of a mixture of the aforesaid compounds, and transforming the salt of acetoacetamide-N-sulfofluoride obtained into the oxathiazinone salt or the free oxathiazinone by a treatment with aqueous and/or alcoholic bases.
[US3968107A]
Patent IE-34817-L (IE)
Title: Air conditioning apparatus
IPC: F24F1/0071
Filed: 1970-12-14
Abstract: A local air conditioning apparatus for installations with distribution of secondary water through four pipes, comprising two heat-exchangers housed in two different chambers with an interposed neutral or by-pass chamber, and a fan for conveying the air to be conditioned through one or two of said chambers, said fan being rotatable so that its outlet can be adjusted in a stepless way to correspond with the inlet of one of the chambers or bridging the inlet of two adjacent chambers.
[US3708011A]
Patent IE-791794-L (IE)
Title: Base for a bed
IPC: A47C19/00
Filed: 1979-09-21
Abstract: A base for a bed comprising (preferably two or four) light-weight thermoplastics platforms 1,2,3,4); interlocked together by couplings which engage skirts 126,42b) and lugs (44b) depending from the platforms so as to prevent rotation of one platform relative to another. The platforms are easily separated for transport by a vertical lifting force yet they resist separation by unintentional rotational forces caused by sitting on or lifting their peripheral edges.
Patent IE-861914-L (IE)
Title: Controlled release pharmaceutical
IPC: A61K9/20
Filed: 1986-07-18
Abstract: The pharmaceutical composition is in the form of a carrier material with a pharmaceutical agent with controlled and delayed release of agent. The release of the agent can be adjusted by varying the particle size and the glass transition temperature.
Patent IE-882348-L (IE)
Title: Selective amplification of target polynucleotide sequences
IPC: C12Q1/6893
Filed: 1988-07-29
Abstract: A method is provided for multiplying the number of copies of a target polynucleotide sequence comprising a series of primer hybridization, extending, and denaturing steps to provide an intermediate double-stranded DNA molecule containing a promoter sequence (through the use of a promoter-sequence-containing primer) incorporated upstream from the target sequence. The double-stranded DNA intermediate is then used to grow multiple RNA copies of the target sequence. The resulting RNA copies can be used as target sequences to produce further copies. Multiple cycles of this sort can thereby exponentially increase the number of target sequence copies.
Patent IE-46094-L (IE)
Title: 0, 0-diaryl n-phosphonomethylglycinonitrile dimers;¹herbicides
IPC: A01N57/22
Filed: 1977-11-18
Abstract: The herbicide contains a herbicidally effective amount of a compound of the formula <IMAGE> and an inert diluent. In the herbicidal procedure, a plant is brought into contact with a herbicidally effective amount of a compound of the formula I. The active substances of the formula I are prepared by heating a mixture of a sterically hindered phenylazomethine and a compound of the formula: <IMAGE> in vacuo until the evolution of the sterically hindered aniline comes to an end.
[GB1561317A]
Patent IE-872433-L (IE)
Title: Mono and diacyl derivatives of ll-f28249 compounds
IPC: A01N43/90
Filed: 1987-09-11
Abstract: The present invention relates to novel 5-acyl, 23-acyl and 5,23-diacyl derivatives of the LL-F28249 compounds. These LL-F28249 compounds (collectively) are isolates from the fermentation broth of Streptomyces cyaneogriseus subspecies noncyanogenus having deposit accession number NRRL 15773. The present 5-acyl and 5,23-diacyl compounds are prepared by selective acylation using acid chlorides or anhydrides in the presence of 4-dimethylaminopyridine. The 23-acyl compounds are prepared by selective acylation of the 5-O-silylated LL-F28249 compounds. These novel compounds have potent anthelmintic, insecticidal, ectoparasiticidal, nematicidal and acaricidal activity. Compositions containing these derivatives of LL-F28249 also are described herein.